Author,Exposure,Outcome,Direction,Strength
DeFilippis 2019,not excessive),troponin elevation,Increase,6.0
,not excessive),mortality,Decrease,6.0
,not excessive),FIRST ISCHEMIC STROKE,Increase,4.34
,not excessive),nt-pro-BNP,Increase,3.22
,not excessive),FIRST ISCHEMIC STROKE,Increase,5.1
,not excessive),FIRST ISCHEMIC STROKE,Increase,5.0
,acute heart failure,FIRST ISCHEMIC STROKE,Increase,3.92
,acute heart failure,mortality,Increase,6.84
,acute heart failure,chronic heart failure,Decrease,3.92
,age,atrial fibrillation,Increase,4.34
,age,BMI,Increase,4.52
,age,FIRST ISCHEMIC STROKE,Increase,6.84
,age,cardiac thrombus,Decrease,2.72
Strohle et al 2015,age,kognitive decline,Decrease,3.0
Hernán et al. 2002,Alcohol intake,Plasma folate levels,Decrease,2.0
Hernán et al. 2002,Alcohol intake,Birth defects,Increase,2.0
,anticoagulation,mortality,Increase,3.22
Wiktor 2018,anticoagulation,FIRST ISCHEMIC STROKE,Increase,3.0
,anticoagulation,severe arrrhythmia,Increase,3.76
Hernán et al. 2002,Antiepileptic drugs,Plasma folate levels,Decrease,2.0
Hernán et al. 2002,Antiepileptic drugs,Birth defects,Increase,2.0
,atherosclerosis,myocardial infarction (type 1),Increase,6.84
"thygesen et al 2018, McAloon 2016",atherosclerosis,mortality,Increase,6.0
scheitz 2018,atrial fibrillation,acute heart failure,Increase,3.0
,atrial fibrillation,troponin elevation,Increase,6.0
scheitz 2014,atrial fibrillation,higher fitness/mobility post,Decrease,3.0
,atrial fibrillation,FIRST ISCHEMIC STROKE,Increase,6.84
,BMI,second ischemic stroke,Increase,6.84
,BMI,atrial fibrillation,Increase,2.52
,BMI,FIRST ISCHEMIC STROKE,Increase,4.34
scheitz et al 2018,cardiac autonomic dysbalance,severe arrrhythmia,Increase,6.0
,cardiac thrombus,higher fitness/mobility post,Decrease,2.68
"Bishop, Lu, & Yankner, 2010",chronic heart failure,kognitive decline,Increase,4.0
,chronic heart failure,FIRST ISCHEMIC STROKE,Decrease,4.34
Krause et al 2017,chronic heart failure,troponin elevation,Increase,6.0
Diener 2020,chronic heart failure,FIRST ISCHEMIC STROKE,Decrease,3.0
,depression,cardiac autonomic dysbalance,Increase,2.72
Scheitz 2018,depression,elevated catecholamines,Increase,2.0
van der Linden 2017,depression,troponin elevation,Increase,2.0
Sandoval 2019,diabetes,myocardial infarction (type 2),Increase,4.0
Faria et al 2020,diabetes,troponin elevation,Increase,4.0
,diabetes,mortality,Increase,4.52
,diabetes,mortality,Increase,6.68
,diabetes,dysphagia,Increase,3.22
,diabetes,diabetes,Increase,4.52
,dissection,Takotsubo syndrome,Decrease,2.68
"Scheitz, Templin 2021 under review",dysphagia,Takotsubo syndrome,Increase,3.0
Thygesen 2018,exercise (cardiac,cardiac thrombus,Increase,5.0
,exercise (cardiac,acute heart failure,Increase,5.1
,exercise (cardiac,myocardial infarction (type 1),Increase,6.0
McCarthy et al 2018,exercise (cardiac,mortality,Increase,6.0
Diener 2020,exercise (cardiac,FIRST ISCHEMIC STROKE,Decrease,4.0
,exercise (cardiac,FIRST ISCHEMIC STROKE,Increase,3.22
,FIRST ISCHEMIC STROKE,second ischemic stroke,Increase,4.34
Ghadri et at 2018,FIRST ISCHEMIC STROKE,troponin elevation,Increase,4.0
,FIRST ISCHEMIC STROKE,infection,Increase,3.22
,FIRST ISCHEMIC STROKE,mortality,Increase,6.0
,FIRST ISCHEMIC STROKE,troponin elevation,Increase,6.0
,FIRST ISCHEMIC STROKE,mortality,Increase,6.54
Ghadri 2018,FIRST ISCHEMIC STROKE,Takotsubo syndrome,Increase,2.0
,FIRST ISCHEMIC STROKE,kognitive decline,Increase,4.52
,FIRST ISCHEMIC STROKE,FIRST ISCHEMIC STROKE,Increase,2.68
,FIRST ISCHEMIC STROKE,nt-pro-BNP,Increase,6.0
,FIRST ISCHEMIC STROKE,dissection,Increase,3.92
,FIRST ISCHEMIC STROKE,cardiac autonomic dysbalance,Increase,4.0
,FIRST ISCHEMIC STROKE,second ischemic stroke,Increase,6.84
Diener 2020,higher fitness/mobility post,mortality,Increase,6.0
,higher fitness/mobility pre,higher fitness/mobility post,Decrease,4.34
Sandoval 2019,higher fitness/mobility pre,myocardial infarction (type 2),Increase,4.0
Rizas et al 2017,hyperlipidemia,cardiac autonomic dysbalance,Increase,6.0
Diener 2020,hyperlipidemia,second ischemic stroke,Decrease,3.0
,hypertension,nt-pro-BNP,Increase,6.0
,hypertension,myocardial infarction (type 1),Increase,6.84
,hypertension,chronic heart failure,Increase,5.1
Ghadri 2018,hypertension,Takotsubo syndrome,Increase,6.0
,hypertension,atherosclerosis,Increase,6.84
,hypertension,depression,Increase,4.61
Thygesen 2018,infection,acute heart failure,Increase,6.0
,infection,infection,Increase,3.22
,myocardial infarction (type 1),hypertension,Decrease,3.92
thygesen et al 2018,myocardial infarction (type 1),troponin elevation,Increase,6.0
,myocardial infarction (type 1),myocardial infarction (type 1),Increase,6.84
,myocardial infarction (type 1),mortality,Increase,2.68
,myocardial infarction (type 1),myocardial infarction (type 1),Increase,6.84
,myocardial infarction (type 1),myocardial infarction (type 1),Increase,6.84
,myocardial infarction (type 1),chronic heart failure,Increase,6.84
thygesen et al 2018,myocardial infarction (type 1),severe arrrhythmia,Increase,6.0
Thygesen 2018,myocardial infarction (type 2),myocardial infarction (type 2),Increase,6.0
McCarthy 2018,myocardial infarction (type 2),myocardial infarction (type 2),Increase,6.0
,persistent foramen ovale,infection,Increase,3.22
Hernán et al. 2002,Plasma folate levels,Birth defects,Decrease,2.0
Scheitz et al 2014,second ischemic stroke,troponin elevation,Increase,6.0
,seizures,FIRST ISCHEMIC STROKE,Increase,4.52
broersen et al 2020,seizures,kognitive decline,Increase,4.0
,severe arrrhythmia,FIRST ISCHEMIC STROKE,Increase,6.68
"Scheitz et al, Sposato 2020",sex (male),elevated catecholamines,Increase,2.0
,sex (male),smoking,Increase,3.84
,sex (male),FIRST ISCHEMIC STROKE,Increase,4.34
,smoking,myocardial infarction (type 1),Decrease,2.72
,smoking,FIRST ISCHEMIC STROKE,Increase,6.84
,stroke lesion affecting central autonomic network,severe arrrhythmia,Increase,6.0
Scheitz et.al 2018 lancet,stroke lesion affecting central autonomic network,severe arrrhythmia,Increase,6.0
Rizas et al 2017,Takotsubo syndrome,severe arrrhythmia,Increase,4.0
,troponin elevation,kognitive decline,Increase,4.52
,troponin elevation,seizures,Increase,4.17
